E-LIB Suche - Ergebnisse für: Cater, Nilo B.

1

Addressing residual risk beyond statin therapy: New targets..:

Mach, François ; Visseren, Frank L.J. ; Cater, Nilo B....
Journal of Clinical Lipidology. , 2024

2

Ertugliflozin and hospitalization for heart failure across ..:

Pandey, Ambarish ; Kolkailah, Ahmed A ; Cosentino, Francesco...
European Heart Journal. 44 (2023) 48 - p. 5163-5166 , 2023

Link: https://doi.org/10.1093/..

3

Potential for residual cardiovascular risk reduction: Eligi..:

Kim, Joseph M. ; Bhatt, Deepak L. ; Dagogo‐Jack, Samuel...
Diabetes, Obesity and Metabolism. 25 (2023) 5 - p. 1398-1402 , 2023

Link: https://doi.org/10.1111/..

4

Efficacy and Safety of Ertugliflozin Added to Metformin: A ..:

Ji, Linong ; Liu, Jie ; Xu, Zhi Jin...
Diabetes Therapy. 14 (2023) 2 - p. 319-334 , 2023

Link: https://doi.org/10.1007/..

5

Cardiorenal outcomes by indices of liver steatosis and fibr..:

Corbin, Karen D. ; Dagogo‐Jack, Samuel ; Cannon, Christopher P....
Diabetes, Obesity and Metabolism. 25 (2022) 3 - p. 758-766 , 2022

Link: https://doi.org/10.1111/..

6

Ertugliflozin and incident obstructive sleep apnea: an anal..:

Wojeck, Brian S. ; Inzucchi, Silvio E. ; Neeland, Ian J....
Sleep and Breathing. 27 (2022) 2 - p. 669-672 , 2022

Link: https://doi.org/10.1007/..

7

Mediators of ertugliflozin effects on heart failure and kid..:

Segar, Matthew W. ; Kolkailah, Ahmed A. ; Frederich, Robert...
Diabetes, Obesity and Metabolism. 24 (2022) 9 - p. 1829-1839 , 2022

Link: https://doi.org/10.1111/..

8

Cardiorenal Outcomes With Ertugliflozin by Baseline Metform..:

Cosentino, Francesco ; Cannon, Christopher P. ; Frederich, Robert...
Circulation. 146 (2022) 8 - p. 652-654 , 2022

Link: https://doi.org/10.1161/..

9

Efficacy and safety of ertugliflozin in East/Southeast Asia..:

Liu, Jie ; Patel, Shrita ; Cater, Nilo B....
Diabetes, Obesity and Metabolism. 22 (2020) 4 - p. 574-582 , 2020

Link: https://doi.org/10.1111/..

10

Apixaban compared to heparin/vitamin K antagonist in patien..:

Ezekowitz, Michael D ; Pollack Jr, Charles V ; Halperin, Jonathan L...
European Heart Journal. 39 (2018) 32 - p. 2959-2971 , 2018

Link: https://doi.org/10.1093/..

11

Comparison of Atorvastatin 80 mg/day Versus Simvastatin 20 ..:

Pedersen, Terje R. ; Cater, Nilo B. ; Faergeman, Ole...
The American Journal of Cardiology. 106 (2010) 3 - p. 354-359 , 2010

Link: https://doi.org/10.1016/..

12

Adherence-adjusted efficacy with intensive versus standard ..:

Holme, Ingar ; Szarek, Michael ; Cater, Nilo B....
European Journal of Cardiovascular Prevention & Rehabilitation. 16 (2009) 3 - p. 315-320 , 2009

Link: https://doi.org/10.1097/..

13

Comparison of Efficacy and Safety of Atorvastatin (80 mg) t..:

Tikkanen, Matti J. ; Holme, Ingar ; Cater, Nilo B....
The American Journal of Cardiology. 103 (2009) 5 - p. 577-582 , 2009

Link: https://doi.org/10.1016/..

14

206:

Kastelein, John J.P. ; Holme, Ingar ; van der Steeg, W.A....
Journal of Clinical Lipidology. 1 (2007) 2 - p. 157 , 2007

Link: https://doi.org/10.1016/..

15

204:

Holme, Ingar ; Szarek, Michael ; Cater, Nilo B..
Journal of Clinical Lipidology. 1 (2007) 2 - p. 156-157 , 2007

Link: https://doi.org/10.1016/..